Bio Pharma Dive
DECEMBER 3, 2020
A closely watched gene editing therapy, a slate of new multiple myeloma drugs and much more are set to highlight the American Society of Hematology conference this weekend.
World of DTC Marketing
DECEMBER 3, 2020
Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. Today consumers don’t run to their doctor after seeing a DTC ad, they do their research, and in some cases, the ads actually help them identify potential health problems. It’s been a while since I’ve seen any research on DTC TV ads’ effectiveness, but a couple of years it was estimated that TV ads were 7% effective.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 3, 2020
The U.S. government has ramped up spending on Lilly's and Regeneron's antibody-based COVID-19 treatments, but each remain in short supply.
Pharma Mirror
DECEMBER 3, 2020
The keto diet, also known as a ketogenic diet, is a type of food-based lifestyle that many people adopt. Essential, it lets you eat foods that are very high in fat and low in carbohydrates. The keto diet lowers insulin levels and increases your body’s ability to burn fat. This diet type is very alluring as it keeps you healthy and feeling full, unlike other diets.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
DECEMBER 3, 2020
What are the critical needs your commercial model must address to deliver a best-in-class experience?
BioSpace
DECEMBER 3, 2020
Vaccine development is an arduous process, taking about 10-15 years on average to accomplish. But with the imminent worries surrounding the COVID-19 pandemic putting unprecedented pressure on our healthcare systems and economies, unprecedented measures needed to be put in place.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
DECEMBER 3, 2020
the robustness and independence of FDA review – even under an EUA – is an important factor in encouraging a skeptical public to accept COVID-19 vaccinations.
NY Times
DECEMBER 3, 2020
IBM has found that companies and governments have been targeted by unknown attackers, prompting a warning from the Homeland Security Department.
BioPharma Reporter
DECEMBER 3, 2020
Janssen Pharmaceuticals, Inc. has acquired the rights to Hemera Biosciencesâ investigational gene therapy HMR59: which has been designed to help preserve vision in patients with severe age-related macular degeneration (AMD).
BioSpace
DECEMBER 3, 2020
Governments across the globe have flexed their financial muscles to secure promises of as many doses of COVID-19 vaccines as possible when they become available.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
DECEMBER 3, 2020
Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel DNA damage response targets in cancer. The principle of DNA damage response is already being exploited by AstraZeneca and other companies with their poly (ADP-ribose) polymerase (PARP) inhibitor drugs. These target the inherent genetic instability in certain cancer cells, which have switched to a backup mechanism to repair damage to their DNA code.
Scienmag
DECEMBER 3, 2020
New insights into protein structures could help inform drug development and predict future outbreaks Credit: Rodrigues et al. 2020 (CC-BY 2.0) Some animals are more susceptible to Covid-19 infection than others, and new research suggests this may be due to distinctive structural features of a protein found on the surface of animal cells. João Rodrigues […].
pharmaphorum
DECEMBER 3, 2020
As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after the initial infection has been fought off. PureTech has joined the effort to find ways to treat the scarring and inflammation that are thought to cause the ongoing symptoms such as shortness of breath and fatigue. After promising results in an early stage study, the company has begun a phase 2 trial of its LYT-100 (deupirfenidone) in Long COVID respiratory complications and related seque
BioSpace
DECEMBER 3, 2020
As if attempting to steal hard-won research wasn’t bad enough, hackers are now hitting people where it really hurts – with e-documents containing malicious code embedded in false offers of employment.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioPharma Reporter
DECEMBER 3, 2020
ERS Genomics, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by the one of the joint 2020 Nobel Prize winners for Chemistry, Dr Emmanuelle Charpentier, has granted a non-exclusive license agreement to German startup, Vivlion.
BioSpace
DECEMBER 3, 2020
Nucleic-acid-based assays are the gold standard for detecting the presence of the SARS-CoV-2 virus, but they eventually will be replaced with simpler and more advanced techniques, such as CRISPR-Cas, LAMP, and other faster and less-expensive methods.
Pharma Times
DECEMBER 3, 2020
Drug Safety Research Unit set to conduct active surveillance study on COVID-19 vaccines
BioSpace
DECEMBER 3, 2020
BioCryst Pharmaceuticals, Inc. announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved ORLADEYO (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and young patients 12 years and older.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
DECEMBER 3, 2020
Study by Brazilian researchers reported in Nature Communications shows that trees are growing faster in forests worldwide, including the Amazon, but their lives are getting shorter Credit: Roel Brienen/University of Leeds Accelerating tree growth in recent years has been accompanied by a reduction in tree lifespan, which could eventually neutralize part of the increase in […].
BioSpace
DECEMBER 3, 2020
Merck KGaA and Artios Pharma Limited announced today that they have entered a strategic collaboration agreement to discover and develop multiple precision oncology drugs over the course of the next three years.
Pharma Times
DECEMBER 3, 2020
Partnership will seek to develop small molecules for oncology/immunology targets
pharmaphorum
DECEMBER 3, 2020
TV viewing habits are changing dramatically, and these trends have only been accelerated by COVID-19 – but Intouch’s Justin Chase says that pharma is still stuck in a traditional advertising mindset. Drawing on research from a recent whitepaper, he tells us how the industry can optimize its TV advertising for an age of hyper-targeted media and modern marketing methodology.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
DECEMBER 3, 2020
Australian research voyage to investigate how life in the Southern Ocean captures and stores carbon from the atmosphere Credit: CSIRO A fleet of new-generation, deep-diving ocean robots will be deployed in the Southern Ocean, in a major study of how marine life acts as a handbrake on global warming. The automated probes will be looking […].
Triage Cancer
DECEMBER 3, 2020
Think all workers can participate in a retirement plan? Think again! According to a 2019 study by the Pension Rights Center* out of 139 million full and part-time workers, only 56% are participating in a work sponsored retirement plan. Only 12% of employers with less than 100 employees even offer a 401(k) plan**. As usual, the people left out of the retirement planning picture are disproportionately women, minorities, and workers in lower paying service jobs.
Scienmag
DECEMBER 3, 2020
Credit: Chris Adam/Purdue University WEST LAFAYETTE, Ind. – During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course. Now, Purdue University is joining with other organizations for an initiative to […].
NY Times
DECEMBER 3, 2020
Marketed as “missed-period pills,” abortion drugs administered as early as 28 days after a woman’s last period can offer comfort in uncertainty to those who want it.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
DECEMBER 3, 2020
Credit: Credit: Vladislav Nikonov/Unsplash It’s a peanut-filled world–or at least it can feel that way for kids with peanut allergies. But a new study by researchers at the University of British Columbia and BC Children’s Hospital gives hope to parents and kids who face real danger from exposure to peanuts. “There’s a common misperception about […].
Pharma Times
DECEMBER 3, 2020
Platform will enable Bayer to pursue external collaborations and bolster internal capabilities
Scienmag
DECEMBER 3, 2020
A study published in Ecological Monographs shows that sugar maple microbiomes change from north to south along the transition from coniferous to deciduous forest Credit: Geneviève Lajoie. Forest leaves are teeming with bacterial life – but despite the vast extent of bacteria-covered foliage across the world, this habitat, known as the phyllosphere, remains full of […].
BioSpace
DECEMBER 3, 2020
Like the Grinch’s heart at Christmas, the Nasdaq Exchange grew a little bigger this week with multiple life science companies raising hundreds of millions of dollars in initial public offerings.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
340 
Let's personalize your content